Literature DB >> 212757

Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

J R Patsch, A M Gotto, T Olivercrona, S Eisenberg.   

Abstract

The effects of lipolysis of human plasma very low density lipoprotein (VLDL) on the structure and composition of high density lipoproteins (HDL) have been investigated. Lipolysis was performed in a controlled system in vitro containing VLDL (d less than 1.006 g/ml) and HDL3 (d = 1.125-1.210 g/ml) from human plasma and lipoprotein lipase (EC 3.1.1.34) purified from bovine milk. Lipolysis of VLDL caused profound changes in HDL3. Protein, phospholipid, and cholesterol liberated from VLDL during its lipolysis were transferred to the HDL3 particles. As a consequence of this in vitro transfer, the chemical composition and biophysical properties of HDL3 were substantially altered. The newly formed particles exhibited a flotation rate (F01.20) of 6.7 and a hydrated density of 1.110 g/ml. The chemical composition closely resembled that of native HDL2, and their size was slightly larger than that of the precursor HDL3. When HDL3 and postlipolysis HDL2 were subjected to ultracentrifugation under flotation velocity and equilibrium conditions, both proved to be stable particles. These results, when extrapolated to in vivo conditions, suggest an important metabolic relationship between the levels of circulating VLDL and HDL2 in plasma. This relationship now permits a reasonable explanation for numerous in vivo observations in which the levels of VLDL and HDL2 change reciprocally.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212757      PMCID: PMC336147          DOI: 10.1073/pnas.75.9.4519

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X1, LP-X2, and LP-X3.

Authors:  J R Patsch; K C Aune; A M Gotto; J D Morrisett
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

3.  Particle distribution of human serum high density lipoproteins.

Authors:  D W Anderson; A V Nichols; T M Forte; F T Lindgren
Journal:  Biochim Biophys Acta       Date:  1977-07-22

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Rat intestine secretes discoid high density lipoprotein.

Authors:  P H Green; A R Tall; R M Glickman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart.

Authors:  T Chajek; S Eisenberg
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

7.  Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation.

Authors:  W Patsch; J R Patsch; G M Kostner; S Sailer; H Braunsteiner
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

8.  Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.

Authors:  J R Patsch; D Yeshurun; R L Jackson; A M Gotto
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Phospholipid removal during degradation of rat plasma very low density lipoprotein in vitro.

Authors:  S Eisenberg; D Schurr
Journal:  J Lipid Res       Date:  1976-11       Impact factor: 5.922

View more
  72 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

Review 3.  Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary.

Authors:  Dhruv Kazi; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 4.  Prescribing aerobic exercise for the regulation of postprandial lipid metabolism : current research and recommendations.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

Authors:  B H Chung; J P Segrest; K Smith; F M Griffin; C G Brouillette
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Tamoxifen-induced modification of serum lipoprotein phospholipids in the cockerel.

Authors:  W C Breckenridge; C B Lazier
Journal:  Lipids       Date:  1987-07       Impact factor: 1.880

7.  The acute effect of marathon running on plasma lipoproteins in female subjects.

Authors:  E R Skinner; C Watt; R J Maughan
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

8.  Adrenergic mechanisms in control of plasma lipid concentrations.

Authors:  J L Day; J Metcalfe; C N Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-17

9.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.

Authors:  A Rubinstein; J C Gibson; J R Paterniti; G Kakis; A Little; H N Ginsberg; W V Brown
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.